GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Hangzhou Tigermed Consulting Co Ltd (SZSE:300347) » Definitions » Revenue

Hangzhou Tigermed Consulting Co (SZSE:300347) Revenue : ¥7,384 Mil (TTM As of Dec. 2023)


View and export this data going back to 2012. Start your Free Trial

What is Hangzhou Tigermed Consulting Co Revenue?

Hangzhou Tigermed Consulting Co's revenue for the three months ended in Dec. 2023 was ¥1,734 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ¥7,384 Mil. Hangzhou Tigermed Consulting Co's Revenue per Share for the three months ended in Dec. 2023 was ¥2.01. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ¥8.53.

Warning Sign:

Hangzhou Tigermed Consulting Co Ltd revenue growth has slowed down over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Hangzhou Tigermed Consulting Co was 4.20% per year. During the past 3 years, the average Revenue per Share Growth Rate was 28.80% per year. During the past 5 years, the average Revenue per Share Growth Rate was 25.10% per year. During the past 10 years, the average Revenue per Share Growth Rate was 30.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Hangzhou Tigermed Consulting Co's highest 3-Year average Revenue per Share Growth Rate was 47.10% per year. The lowest was 20.40% per year. And the median was 30.35% per year.


Hangzhou Tigermed Consulting Co Revenue Historical Data

The historical data trend for Hangzhou Tigermed Consulting Co's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou Tigermed Consulting Co Revenue Chart

Hangzhou Tigermed Consulting Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,803.31 3,192.28 5,213.54 7,085.47 7,384.04

Hangzhou Tigermed Consulting Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,679.45 1,804.57 1,906.28 1,939.63 1,733.56

Competitive Comparison of Hangzhou Tigermed Consulting Co's Revenue

For the Diagnostics & Research subindustry, Hangzhou Tigermed Consulting Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hangzhou Tigermed Consulting Co's Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Hangzhou Tigermed Consulting Co's Revenue distribution charts can be found below:

* The bar in red indicates where Hangzhou Tigermed Consulting Co's Revenue falls into.



Hangzhou Tigermed Consulting Co Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥7,384 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hangzhou Tigermed Consulting Co  (SZSE:300347) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Hangzhou Tigermed Consulting Co Revenue Related Terms

Thank you for viewing the detailed overview of Hangzhou Tigermed Consulting Co's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Hangzhou Tigermed Consulting Co (SZSE:300347) Business Description

Traded in Other Exchanges
Address
Block 8, No. 19 Jugong Road, Room 2001-2010, 20th Floor, Xixing Sub-District, Binjiang District, Hangzhou, CHN, 310053
Hangzhou Tigermed Consulting Co Ltd is a China-based Contract Research Organization. The company's segment includes Clinical trial solutions and Clinical-related and laboratory services. It generates maximum revenue from the Clinical trial solutions segment. The company's offered services include bioanalytical, medical writing, biostatistics analysis, and medical imaging. The therapeutic areas of the company include Infections, Hematology, Cardiovascular, Endocrinology, Rheumatology, Nephrology, and Central Nervous System (CNS) among others.

Hangzhou Tigermed Consulting Co (SZSE:300347) Headlines

No Headlines